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repeat-PCI (1% vs 2.7 %, p = 0.005), need for urgent CABG (0.1% vs 1.3 %, p = 0.03),
seven months MACE (1% vs 3.1 %, p = 0.029), seven months TVR (11 % vs 19.9%, p =
0.001), combined MACE /TVR at seven months (14.9 % vs 26.9 %, p = 0.001) and death
at seven months (1 % vs 3.1 %, p = 0.029).
Conclusion: Analysis of our large database of bifurcation lesions shows that provisional
T stenting is the sole modifiable predictor associated with a reduction in target vessel
revascularization as well as MACE and should be the preferred strategy for coronary
bifurcation lesion PCI.
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878-6 Stenting Under Intravascular Ultrasound Guidance of 
Coronary Bifurcation Lesions With a New Device 
Allowing Provisional Side Branch Treatment
Wim J. Vander Giessen, Jurgen R. Ligthart, Pieter C. Smits, Pim J. de Feyter, George 
Sianos, Thierry Lefèvre, Patrick W. Serruys, Thoraxcenter, Erasmus MC, Rotterdam, The 
Netherlands
Background: A new stent (MULTI-LINK FRONTIER) was developed for coronary bifur-
cation lesions. It is an 18 mm stent premounted on a delivery system with 2 balloons. The
device is positioned by pushing it up to the carina of the bifurcation. Simultaneous infla-
tion of the balloons deploys the main branch (MB) stent and opens up a portal to the side
branch (SB). We studied intravascular ultrasound (IVUS) parameters and their relation to
procedural success and 6-month outcome.
Methods: Patients with (un)stable angina pectoris and de novo or restenotic (no previous
stent) bifurcation lesion between 2.5 and 4 mm in diameter for the main branch and
>2.0mm for the side branch were eligible. Exclusion criteria were angiographic severe
calcification, thrombus or left main lesion. Pre-, post-, and at follow-up IVUS was per-
formed in MB and SB using a 30 MHz catheter and automated pull-back.
Results: 18 patients were included: male 14, age 62 (13) year. The LAD/diag bifurcation
was the target lesion in 17/18. After IVUS and mandatory predilatation stent implantation
was successful in 16 (89%). Failure to wire the SB or to position the catheter in phase
with the SB were the cause. Implantation at the carina succeeded in 12/16 (75%). The
cases with ”carina failure” had longer segments with calcified plaque proximal to the car-
ina than cases with “carina success” (25 (14) vs 11 (11) mm; P<0.05) as assessed by
IVUS. The presence of calcium per se, or its circumferential angle or whether superficial
or deep was not associated with carina failure. Carina failure resulted in (partial) overlap
of the stent with the ostium of the SB in 75%. Carina failure or SB overlap was not asso-
ciated with SB restenosis. MLA by IVUS pre-, post-, and at 6 months FU was 2.3 (1.2)
mm2, 7.3 (2.2) mm2, and 4.2 (1.0) mm2, resp. (P<0.05). At FU there were no deaths or
MI’s. Target vessel revascularization occurred in 3 patients (16.6%). Angiographic rest-
enosis (>50% DS) occurred in 18.8% in the Frontier stent MB and in 12.5% in the SB,
overall 31.3%.
Conclusion: This bifurcation stent can be implanted in about 90% of lesions, with prom-
ising 6 months adverse event rate. Longer proximal calcified segment is associated with
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880-1 Repeat Intracoronary Gamma Radiation for Patients 
With In-Stent Restenosis Who Failed Radiation 
Therapy: Results From the Re-WRIST Clinical Trial
Ron Waksman, Andrew E. Ajani, Rebecca Torguson, Donna J. Whitman, Daniel A. 
Canos, Regina Deible, Lowell F. Satler, William O. Suddath, Augusto D. Pichard, Kenneth 
M. Kent, Joseph Lindsay, Washington Hospital Center, Washington, DC
Background: Intracoronary radiation (IR) is an effective therapy for preventing the recur-
rence of in-stent restenosis (ISR). However, nearly 20% of patients enrolled in radiation
studies required repeat revascularization to the irradiated site. Re-WRIST is a registry
evaluating the safety and efficacy of retreatment with IR.
Methods: Thirty pts (31 lesions) with ISR at the previously irradiated segment and who
failed a subsequent angioplasty without radiation were eligible for retreatment with IR.
The Checkmate radiation system using Ir-192 seeds was udes, and the repeat was pre-
scribed dose was 15 Gy at 2 mm. The antiplatlet regimen post procedure was lifelong
aspirin and at least 6 months of clopidogrel.
Results: Pts mean age was 65±7.9 yrs, 67% were males, 52% were diabetic, and 90%
had CABG. Lesions were in native coronaries 67.7%, saphenous vein grafts 29.0%, and
the left internal mammary 3.3%. Time between radiation treatments was 16.4±8.7 mos
and the number of interventions to the target lesion was 5.2±3.5 (range 3-20). The lesion
length was 21.74±14.25 mm. At 9 mos, the major adverse cardiac events rate was 36%,
target lesion revascularization 32%, MI 0%, and deaths 4%. QCA at 9 months demon-
strated a restenosis rate of 35%. There was one late total occlusion and no angiographic
complications (evidence of aneurysm, fibrosis, perforation) in any of the pts.
Conclusions: Repeat radiation to the same site using Ir-192 for refractory ISR is safe
and should be considered an option in this difficult patient subset. 
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880-2 Randomized Comparison of Rotational Atherectomy 
and Cutting Balloon Angioplasty Followed by Radiation 
Therapy With a 188Re-MAG3-Filled Balloon in the 
Treatment of Diffuse In-Stent Restenosis
Seong-Wook Park, Seung-Whan Lee, Young-Hak Kim, Ki-Hoon Han, Cheol Whan Lee, 
Myeong-Ki Hong, Jae-Joong Kim, Seung-Jung Park, Asan Medical Center, Seoul, South 
Korea
Background: Randomized comparison of rotablation atherectomy (RA) and cutting bal-
loon angioplasty (CB), followed by beta-radiation for in-stent restenosis (ISR) has not
been reported.
Methods: This randomized controlled study was conducted to compare the efficacy of
RA (n=58) with CB (n=55) prior to beta-radiation therapy with a rhenium-188-mercap-
toacetyltriglycine (188Re-MAG3)-filled balloon for diffuse in-stent restenosis (ISR). The
radiation dose was 18 Gy at a depth of 1.0 mm into the vessel wall.
Results: The baseline clinical and angiographic characteristics were similar between the
2 groups. The lesion length was 21.0±11.2 mm in the RA group and 20.8±10.2 mm in the
CB group (p=0.77). Radiation was delivered successfully to all patients. Adverse events
including myocardial infarction, death, or stent thrombosis did not occurred during the 9-
month follow-up period. Six months angiographic follow-up was obtained in 88 patients
(78%) and the rates of angiographic restenosis was not statistically different between the
RA group (13%, 6/46) and the CB group (12%, 5/42)(p=0.87). The risk of a target lesion
revascularization or a major adverse cardiac event was similar between two groups (RA
group vs CB group: 3.4% vs 3.6%, p=0.94) during 9-month follow-up period.
Conclusions: Concomitant treatment of RA or CB with beta-irradiation using a 188Re-
MAG3-filled balloon for diffuse ISR was safe and had a similarly favorable angiographic
and clinical outcomes.
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880-3 Histopathological Characteristics of Edge Restenosis 
After Intracoronary Brachytherapy for In-Stent 
Restenosis
Masaharu Okada, Hideo Tamai, Eisho Kyo, Kunihiko Kosuga, Tatsuhiko Hata, Takuji 
Nakamura, Shinya Fujita, Takafumi Tsuji, Shinsaku Takeda, Nobutoyo Masunaga, 
Katsuyuki Hasegawa, Seiichiro Motohara, Hiromu Uehata, Shiga Medical Center for 
Adults, Moriyama, Japan
Background: Histopathology of edge restenosis following intracoronary brachytherapy
(BT) has not been fully evaluated in humans. The purpose of this study was to clarify the
histopathological characteristics of edge restenosis following BT by examining the speci-
mens obtained from directional coronary atherectomy (DCA). Methods: Eight edge rest-
enosis lesions which developed in native coronary arteries after BT with the beta-emitting
32P source wire were obtained by DCA and were compared with the restenosis lesion
which developed after ordinary balloon angioplasty without BT (R, 6 lesions). Edge rest-
enosis was defined as a lesion which developed 5 mm proximal or distal to either edge of
32P source wire. Mean interval from BT to edge restenosis was 242±28 days. Specimens
retrieved by DCA were immediately placed in 10% buffered formalin, processed for paraf-
fin embedding and stained with hematoxylin and eosin. To assess the proliferation of
myofibroblast, we categorized the severity as grade 0, 1, 2, and 3 by estimating the cell
density and analyzed by Mann-Whitney U test. Results: 1) Invasion of inflammatory cells
and evidence of vasculitis were not apparent in any of the edge restenosis lesions or R
lesions. 2) In edge restenosis lesions, myofibroblasts were more scarce and active prolif-
Baseline (post procedure) Follow up (9 months)
RVD, mm 2.66+/-0.57 2.62+/-0.58
MLD, mm 2.07+/-0.66 1.61+/-0.98
DS, % 23.53+/-10.5 38.4+/-36.33
In-stent MLD, mm 1.99+/-0.56 1.23+/-0.76
In-stent DS, % 27.75+/-8.48 51.66+/-33.2
In-lesion late loss, mm 0.51+/-0.99
Binary Restenosis, % 35
MLD:minimal lumen diameter
RA group CB group P value
Pre MLD (mm) 0.76±0.37 0.84±0.41 0.30
Post MLD (mm) 2.59±0.39 2.69±0.53 0.30
Follow-up MLD (mm) 2.01±0.66 2.22±0.68 0.15
Acute gain (mm) 1.79±0.54 1.85±0.60 0.58
Late loss (mm) 0.35±0.52 0.54±0.60 0.25
Loss index 0.19±0.36 0.29±0.36 0.34
